Skip to content
Research Article Open access CC BY 3.0

Carcinogen Metabolizing Enzymes: Modulation of Their Activities in Liver, Lung and Stomach by Thymoquinone

Said Al-Dalaen, Samir Mahgoub, Aiman Al-Qtaitat

European Journal of Medicinal Plants · pp. 383–393 · Published 13 Jan 2014

10.9734/EJMP/2014/3870

Abstract

Background: Thymoquinone (TQ), the bioactive constituent of black seed (Nigella sativa), has been shown to inhibit the growth of various human cancerous cells both in vitro and in vivo. Aim: To characterize the effects of thymoquinone on the activity of phase I and phase II carcinogen metabolizing enzymes in rats. Materials and Methods: Phase I enzymes, namely the cytochrome P450 enzymes CYP1A1 and CYP2E1, and phase II enzymes, including UDP-glucuronyltransferase (UGT) and glutathione S-transferase (GST), were studied in the liver, lung and stomach of female Swiss albino rats. The animals were divided into two groups (10 rats/group), a control group treated with corn oil and a TQ-treated group receiving oral (gavage) thymoquinone at a dose of 10 mg/kg/day for 15 consecutive days. Animals were then sacrificed on day 16. Tissue homogenates of liver, lung and stomach were prepared to evaluate the activities of both phase I and phase II selected enzymes. Results: Thymoquinone treatment induced significant modulation of the selected phase I and phase II enzymes in a tissue-specific manner. Our results revealed statistically significant reductions in the activities of CYP1A1 enzyme (46%, 60% and 57% in liver, lung and stomach respectively) versus the control group. Similarly, CYP2E1 activities were decreased in both liver and lung, by 51% and 16%, respectively, compared to the control group. UGT enzyme showed a decrease of 51% in liver, but a significant rise in both lung and stomach, by 40% and 192%, respectively. GST activity, on the other hand, was moderately enhanced, by 24%, 50% and 30% in liver, lung and stomach, respectively. Conclusion: Thymoquinone, in addition to scavenging active metabolites of chemical carcinogens, may also change their metabolisms by modulating the activity levels of enzymes involved in carcinogen activation and/or xenobiotics pathways.  

Thymoquinone drug metabolism black seed Nigella sativa herbal drugs CYP enzymes anticancer

References (40)

  1. 1 PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT [DOI]
  2. 2 Glutathione S-Transferases [DOI]
  3. 3 ETHOXYRESORUFIN: DIRECT FLUORIMETRIC ASSAY OF A MICROSOMAL O-DEALKYLATION WHICH IS PREFERENTIALLY INDUCIBLE BY 3-METHYLCHOLANTHRENE [DOI]
  4. 4 Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects [DOI]
  5. 5 Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes [DOI]
  6. 6 UDP-glucuronosyltransferases and clinical drug-drug interactions [DOI]
  7. 7 The enzymes of detoxication. [DOI]
  8. 8 The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism* † [DOI]
  9. 9 Effects of thymoquinone on antioxidant enzyme activities, lipid peroxidation and DT‐diaphorase in different tissues of mice: a possible mechanism of action [DOI]
  10. 10 Natural Products in the Process of Finding New Drug Candidates [DOI]
  11. 11 The antioxidative and antihistaminic effect of Nigella sativa and its major constituent, thymoquinone on ethanol-induced gastric mucosal damage [DOI]
  12. 12 From here to eternity - the secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond.
  13. 13 Cytochrome P450 Nomenclature [DOI]
  14. 14 Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes [DOI]
  15. 15 Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice [DOI]
  16. 16 Thymoquinone Induces Telomere Shortening, DNA Damage and Apoptosis in Human Glioblastoma Cells [DOI]
  17. 17 A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis.
  18. 18 p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol. [DOI]
  19. 19 Inhibition of carcinogenesis by minor dietary constituents.
  20. 20 Effects of alpha-hederin and thymoquinone, constituents of Nigella sativa, on human cancer cell lines.
  21. 21 CYP1A1 genetic polymorphisms and in situ colorectal cancer.
  22. 22 The alcohol-inducible form of cytochrome P450 (CYP2E1): Role in toxicology and regulation of expression [DOI]
  23. 23 Thymoquinone supplementation induces quinone reductase and glutathione transferase in mice liver: possible role in protection against chemical carcinogenesis and toxicity [DOI]
  24. 24 Inhibition of human cytochrome CYP1 enzymes by flavonoids of St. John's wort [DOI]
  25. 25 Inhibition of two stage renal carcinogenesis, oxidative damage and hyperproliferative response by Nigella sativa [DOI]
  26. 26 Modulation of cytochrome P450 enzymes by organosulfur compounds from garlic [DOI]
  27. 27 Modulatory effect of Henna leaf (Lawsonia inermis) on drug metabolising phase I and phase II enzymes, antioxidant enzymes, lipid peroxidation and chemically induced skin and forestomach papillomagenesis in mice [DOI]
  28. 28 Effect of thymoquinone on 1,2-dimethyl-hydrazine-induced oxidative stress during initiation and promotion of colon carcinogenesis [DOI]
  29. 29 Potential chemoprotective effects of the coffee components kahweol and cafestol palmitates via modification of hepatic N‐acetyltransferase and glutathione S‐transferase activities [DOI]
  30. 30 Modulation of Hepatic Drug Metabolizing Enzymes by Dietary Doses of Thymoquinone in Female New Zealand White Rabbits [DOI]
  31. 31 Studies in the History of Statistics and Probability. [DOI]
  32. 32 Regulation of Rabbit Cytochrome P450 2E1 Expression in HepG2 Cells by Insulin and Thyroid Hormone [DOI]
  33. 33 Inhibition of rat liver UDP-glucuronosyltransferase by silymarin and the metabolite silibinin-glucuronide [DOI]
  34. 34 Upregulation of Chemoprotective Enzymes and Glutathione by Nigella sativa (Black Seed) and Thymoquinone in CCl 4 -Intoxicated Rats [DOI]
  35. 35 Modulation of 3-methylcholanthrene-induced rat hepatic and renal cytochrome P450 and phase II enzymes by plant phenols: protocatechuic and tannic acids [DOI]
  36. 36 Metabolic Activation of 4-Ipomeanol in Human Lung, Primary Pulmonary Carcinomas, and Established Human Pulmonary Carcinoma Cell Lines [DOI]
  37. 37 Chemoprevention: A Primary Cancer Prevention Strategy [DOI]
  38. 38 Protective Effects of Nigella sativa extract against Chromiumvi-Induced Genotoxicity in Nile Tilapia (Oreochromis niloticus) and Zebrafish (Danio rerio)
  39. 39 Developmental alteration of hepatic UDP-glucuronosyltransferase and sulphotransferase towards androsterone and 4-nitrophenol in Wistar rats [DOI]
  40. 40 Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the Seventh DeWitt S. Goodman Lecture.

Cited by 4

Mechanistic perspectives on cancer chemoprevention/chemotherapeutic effects of thymoquinone.

J. Kundu, Kyung-Soo Chun, O. Aruoma · Mutation research · 2014

The efficacy of applying some plants and herbs in cancer therapy for humans and animals – A comprehensive review

Mohamed E. Abd El-Hack, Manal A. Alfwuaires, Muthana M. Jghef · Annals of Animal Science · 2023

Showing 2 of 4 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

19

Page views

0

PDF downloads

1

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.